Milliman IntelliScript

Got FOMA? We do too. Because when you work in risk assessment, you don’t have a fear of missing out—you have a fear of missing ANYTHING. That’s why we relentlessly (maybe a little obsessively) invent #insurtech tools that make it faster than ever to see more risks and seize more opportunities, so you can fearlessly move your business forward. #FearofMissingAnything FOMA-minded candidates who have their pick of jobs are drawn to our culture of innovation and excellence. We're always hiring the best and brightest—check out our current opportunities: https://lnkd.in/gCMN9m9G #MillimanIntelliScript

Much of the wizardry behind our #insurtech tools comes from our clinical team, who are the best in the biz. But don’t just take our word for it. #AAIM has recognized Kimberly Sapre, DMSc, PA-C, CAQ-EM, DFAAPA as its member of the month. It’s a true credit to her that the insurance medical directors we serve and collaborate with chose to showcase her talents and contributions from among its ranks. It’s a privilege to partner with this esteemed organization in shaping the future of the industry. Brava, Kimberly! 

As a teenager you hear from your parents (a lot) that life’s not fair. That may be true, but we think #underwriting should be. That’s why we’re headed to the 2024 SOA ImpACT Conference, October 27–29, to share our thoughts on fairness and bias in underwriting. Don't miss our session co-presented by Sue Bartholf that explores proposed regulations and practices, tools and techniques, and challenges in overcoming bias in underwriting. #Insurance #SOA

Those life insurance applicants you declined? PartnerRe has gone and estimated their average mortality. And WHY would that matter? We’re glad you asked! 🤓 Despite the best #underwriting intentions, some such high risks inevitably slip through. Knowing their mortality is the first step towards understanding their impact on your business. In his brilliant white paper, Ehren Nagel, FSA, MAAA 🧠 made clever use of Irix Risk Score to help answer the question, “Do declinable risks really have 500% relative mortality, or is that another rule of thumb we should reconsider?” It’s a fascinating read. https://lnkd.in/geYJX62Z

Where charity and golf prevail, ⛳ 💙 there Milliman IntelliScript is ever found—along with dozens of other generous co-sponsors. We were delighted to support our friends at Globe LIfe and their 28th Annual Charity Golf Tournament. Not only great fun but a truly worthwhile effort. #community #globelife

Our life sciences team is seeking a #clinicaltrials expert and #SaaS product manager https://lnkd.in/g8J-GSSV to be our resident industry guide and strategist. Can you articulate product value and strategy to internal and external stakeholders—from software engineers and sales reps to sites, CROs, and sponsors? Have you kept tabs on the clinical trials industry for a good while? Help us clear away multi-billion-dollar roadblocks in today’s cumbersome drug-development process to bring our groundbreaking products to market.  #WeAreHiring #lifesciences #productmanager

We turned these four brainiacs 🧠 loose to explore the mortality implications of severe obesity—a condition that affects 9.2% of American adults. In this fascinating Q&A interview, they share how they approached the data with learned preconceptions and showed that millions of people with BMIs ≥40 actually have better-than-average mortality—a notion that is contrary to long-held underwriting standards. https://lnkd.in/gEQ4Jm82 The upshot: life insurers can cover more people and issue more business with more confidence than ever. Great work, team! 👏👏👏 #MeetOurExperts #lifeinsurance #underwriting

Check out Jenna Fariss, ASA, MAAA's eye-opening article in ON THE RISK. Our nicotine mortality study is changing the way insurers view and assess smoker applicants.

We’re spilling the tea ☕ on achieving fast, easy, and accurate #underwriting at NEHOUA, October 17–18. Hayley and Matt will share insider tips on sleuthing out stubbornly hidden conditions, plus they’ll bring you up to speed on recent treatments approved by the FDA and their related mortality implications. Don’t miss it. See you at #NEHOUA!

Look for Angela Bolduc on this panel of industry leaders, "How AI is Revolutionizing the Life Insurance Industry", hosted by our friends at Sikka.ai. She'll be part of discussions about: - How much of the life insurance sales cycle can be automated with generative AI - from lead generation and quoting, underwriting, fraud detection, policy management, and even retention and claims? - How much of the underwriting process could or should be automated, and what are the potential dangers or regulatory impacts? - As the world shifts towards machine learning and AI, how important will investing in and acquiring new data sources be? Mark your calendars for October 24th and join us for this engaging discussion! 🚀 Learn more: https://lnkd.in/g2hCxvP7